Press Releases - 2023-08-29

Date	Title	Company
29-Aug-2023	Novartis presents new long-term Leqvio®▼ (inclisiran) data demonstrating consistent safety profile and efficacy beyond six years	Novartis
29-Aug-2023	Pharmaceutical companies maintain reputation post-pandemic, new research finds	ABPI
29-Aug-2023	KEY HUMAN BLADDER CANCER GENES PINPOINTED IN CATS AND DOGS	Wellcome Sanger Institute
29-Aug-2023	UEA researchers develop new tool to reduce stroke risk	University of East Anglia
29-Aug-2023	Optical Preclinical Imaging Market Set for Exponential Growth, Predicted to Surpass USD 0.85 Billion by 2030	The Wire Times
29-Aug-2023	Insulin Syringes Market Update 2023: Predicted to Surpass USD 2.40 Billion by 2030, Report	The Wire Times
29-Aug-2023	Mainz Biomed to Present at the H.C. Wainwright Global Investment Conference	Mainz BioMed N.V.
29-Aug-2023	Toxoplasmosis Treatment Market Size Worth USD 1.09 Billion, Globally, by 2031 at 4.8% CAGR: AMR	The Wire Times
29-Aug-2023	Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall	Dermapharm Holding SE
29-Aug-2023	Formycon announces File Acceptance for FYB203, a biosimilar candidate to Eylea®1 (aflibercept), by the U.S. Food and Drug Administration (FDA)	Formycon AG
29-Aug-2023	Evotec SE reports results for the first half-year 2023 and provides corporate updates	Evotec SE
29-Aug-2023	Exploring New Frontiers in Drug Delivery: CD Formulation Introduces State-of-the-Art Microsphere and Microneedle Technologies	CD Formulation